Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.

Catalá-López F , Macías Saint-Gerons D , González-Bermejo D , Rosano GM , Davis BR , Ridao M , Zaragoza A , Montero-Corominas D , Tobías A , de la Fuente-Honrubia C , Tabarés-Seisdedos R , Hutton B
PLoS medicine
Medications aimed at inhibiting the renin-angiotensin system (RAS) have been used extensively for preventing cardiovascular and renal complications in patients with diabetes, but data that compare their clinical effectiveness are limited. We aimed to compare the effects of classes of RAS blockers on cardiovascular and renal outcomes in adults with diabetes.

Copyright(C) 2006 BIOIMPACT Co., Ltd. All Rights Reserved